Please assess the completion status of the following clinical trial:

Trial Title: Netarsudil Use After Descemtorhexis Without Endothelial Keratoplasty

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: EARLY_PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Fuchs corneal dystrophy~Exclusion Criteria:~* Women of childbearing potential~* Other corneal eye diseases~* Non-compliance with netarsudil~* Intolerance of netarsudil

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Netarsudil use (Type: EXPERIMENTAL): Patients will receive Netarsudil eye drops to use 1 drop nightly in the operative eye after DWEK surgery until corneal clearance

Based on this trial design, predict the completion outcome and termination type (if applicable).